1. Home
  2. COEP vs EBON Comparison

COEP vs EBON Comparison

Compare COEP & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • EBON
  • Stock Information
  • Founded
  • COEP 2017
  • EBON 2010
  • Country
  • COEP United States
  • EBON China
  • Employees
  • COEP N/A
  • EBON N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • EBON Semiconductors
  • Sector
  • COEP Health Care
  • EBON Technology
  • Exchange
  • COEP Nasdaq
  • EBON Nasdaq
  • Market Cap
  • COEP 30.5M
  • EBON 27.6M
  • IPO Year
  • COEP N/A
  • EBON 2020
  • Fundamental
  • Price
  • COEP $9.48
  • EBON $4.00
  • Analyst Decision
  • COEP
  • EBON
  • Analyst Count
  • COEP 0
  • EBON 0
  • Target Price
  • COEP N/A
  • EBON N/A
  • AVG Volume (30 Days)
  • COEP 42.3K
  • EBON 4.9K
  • Earning Date
  • COEP 05-09-2025
  • EBON 04-25-2025
  • Dividend Yield
  • COEP N/A
  • EBON N/A
  • EPS Growth
  • COEP N/A
  • EBON N/A
  • EPS
  • COEP N/A
  • EBON N/A
  • Revenue
  • COEP N/A
  • EBON $3,591,648.00
  • Revenue This Year
  • COEP N/A
  • EBON N/A
  • Revenue Next Year
  • COEP N/A
  • EBON N/A
  • P/E Ratio
  • COEP N/A
  • EBON N/A
  • Revenue Growth
  • COEP N/A
  • EBON N/A
  • 52 Week Low
  • COEP $2.31
  • EBON $3.80
  • 52 Week High
  • COEP $13.70
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • COEP 45.50
  • EBON 37.45
  • Support Level
  • COEP $9.01
  • EBON $3.80
  • Resistance Level
  • COEP $9.75
  • EBON $4.44
  • Average True Range (ATR)
  • COEP 0.84
  • EBON 0.21
  • MACD
  • COEP -0.03
  • EBON 0.01
  • Stochastic Oscillator
  • COEP 46.07
  • EBON 25.03

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.

Share on Social Networks: